Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease

Volume: 120, Issue: 10, Pages: 18320 - 18331
Published: Jun 18, 2019
Abstract
Alzheimer's disease (AD) is an irreversible, progressive brain disorder responsible for memory loss leading to the inability to carry out the simplest tasks. AD is one of the leading causes of death in the United States. As yet there are no effective medications to treat this debilitating disease. In recent years, a human gene called bridging integrator 1 ( BIN1 ) has emerged as one of the most important genes in affecting the incidence of...
Paper Details
Title
Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease
Published Date
Jun 18, 2019
Volume
120
Issue
10
Pages
18320 - 18331
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.